Visit us at the ADA Annual Session booth 1659. Witness Airocide eliminating glutaraldehyde for yourself.

Airocide DS. Proven Results.

dentists_xray

How Has Airocide Fared in Dental Settings? You Be the Judge.

CASE STUDY ONE // NOTCHVIEW DENTAL

Airborne Bacteria Reduction testing

The dentists as well as the staff at Notchview Dental commented that the air in the offices prior to turning the Airocide’s system on felt “heavy” and usually would burn or sting their eyes by the end of the day. Additionally a new staff person with the practice for just a few months was experiencing a runny nose, nasal irritation and other allergy symptoms within a few days of starting to work in the dental practice.

Researchers performed tests in multiple locations inside the offices of Notchview’s 26,800 ft3 dental practice. Air samples were taken in accordance with protocols and procedures established by the Indoor Air Quality Association (IAQA) and the National Industrial Hygienists Association. The tests resulted in an average 45.3% reduction in airborne bacteria in 24 hours and an average 80% reduction in airborne mold/fungi in the same 24-hour period.


CASE STUDY TWO // HARMOT MEDICAL CENTER

Surgery, Operating Room #6 – Erie, PA
Airborne Bacteria Reduction Testing

Modern operating rooms have high velocity and highly efficient HEPA type filtering systems that effectively reduce CFUs in the operating room prior to the doctors, staff, patient and equipment being introduced into the OR. As all the necessary personnel arrive in surgery, a sudden “spike” of bacterial CFUs takes place.

A baseline air sample showed 565 CFUs before surgery with HEPA filtering in use and the initiation of the NASA-developed technology. Following the surgery and implementation of the PCR unit, the bacterial count was lowered by 50%. When the room was allowed to return to a baseline level, normal for the room, 566 CFUs were found. When an additional unit was introduced into the operating room, the post-operative condition of the OR showed an 85.7% reduction in airborne bacterial CFUs.